Germany Biomaterials in Healthcare Market Report 2022 to 2030

Germany Biomaterials in Healthcare Market Analysis

$ 3999

The Germany Biomaterials Healthcare Market is expected to witness growth from $5.71 Bn in 2022 to $13.56 Bn in 2030 with a CAGR of 11.40% for the forecasted year 2022-2030. A growing need for regenerative medicine and an ageing populace are the main factors driving Germany's biomaterials healthcare market. The market is segmented by type and by application. Some key players in this market include Evonik Industries, Merck KGaA, Matricel, BASF SE, Covestro AG and Celanese.

ID: IN10DEMD003 CATEGORY: Medical Devices GEOGRAPHY: Germany AUTHOR: Jigyasu Bhandari

Buy Now

Germany Biomaterials in Healthcare Market Executive Analysis

The Germany Biomaterials Healthcare Market size is at around $5.71 Bn in 2022 and is projected to reach $13.56 Bn in 2030, exhibiting a CAGR of 11.40% during the forecast period. In 2022, the recent health expenditures in Germany represent 13% of the GDP. Germany's entire health expenditure in 2021 was covered by transfers and assistance from the government totalling $72,05 billion. This marked an increase of $17.30 billion, or 31.5%, from 2020. As a result, government transfers and subsidies accounted for 15.7% of the $4581 billion in current health expenditures, a rise of 3% from the previous year.

In Germany, Biomaterials are substances that engage with biological systems to sustain injured tissues or encourage tissue healing. Dental implants are used to substitute missing teeth and are made of biomaterials like metals, ceramics, and polymers. Orthopaedic implants, such as hip and knee replacements, use biomaterials to assist and encourage healing. To encourage tissue regeneration and lessen scarring, biomaterials are used in the healing of wounds, such as collagen-based dressings. To transport drugs precisely where they are needed and minimise side effects, biomaterials are used in drug delivery, such as implantable drug pumps. In tissue engineering, where cells and biomaterials are combined to make tissue constructs that can be used for transplantation, biomaterials are used. Biomaterials are created to work with biological systems, lowering the possibility of rejection or unfavourable responses. Biomaterials are highly adaptable because they can be created to satisfy particular requirements, such as those for strength, flexibility, or degradation rate. Since biomaterials are made to last a long time, fewer replacement procedures are required. Biomaterials can be made to encourage quicker healing and shorten recovery times. Because they shorten recovery times and eliminate the need for replacement surgeries, biomaterials can lower healthcare expenses.

Germany Biomaterials Healthcare Market Analysis

Market Dynamics

Market Growth Drivers

A growing need for regenerative medicine and an ageing populace are the main factors driving Germany's biomaterials healthcare market. With a goal of enhancing patient outcomes and lowering healthcare expenses, the German government has also been making investments in the development of biomaterials. The demand for medical devices and implants in Germany is anticipated to rise as the country's population ages, boosting the market for biomaterials. As the demand for these therapies rises, the use of biomaterials in regenerative medicine, such as tissue engineering, is anticipated to fuel market growth. The prevalence of chronic conditions like diabetes, arthritis, and cardiovascular diseases is rising, which is expected to increase the demand for biomaterials for managing and treating these diseases.

Market Restraints

In Germany, Smaller businesses of biomaterials may find it difficult to join the German healthcare biomaterials market due to the high cost of biomaterial development. The use of biomaterials in some contexts, such as stem cell research and tissue engineering, may give rise to ethical questions that restrict the use of these products. Germany's biomaterials market is extremely competitive, and manufacturers may find themselves up against well-known goods that are already widely accepted in the German biomaterial healthcare market. Even though patient and healthcare practitioner awareness of the advantages of biomaterials is likely to be low, this may constrain demand for the German biomaterial healthcare market.

Competitive Landscape

Key Players

Evonik Industries (DE)
Merck KGaA (DE)
Matricel (DE)
BASF SE
Celanese
Covestro AG

Notable Recent Deals

2021: Heraeus Medical GmbH declared in 2021 that it had acquired a controlling interest in the nanotechnology firm nanotronics. The goal of the purchase was to broaden Heraeus' selection of biomaterials and hasten the creation of ground-breaking new products.

2020: Evonik Industries AG disclosed in 2020 that it had acquired the American bioscience firm Transferra Nanosciences Inc. The acquisition was made to enhance Evonik's selection of biomaterials for applications in gene therapy and drug delivery.

Healthcare Policies and Regulatory Landscape

Regulations from the European Union, national laws, and regulatory agencies like the Federal Institute for Drugs and Medical Devices and the German Medical Devices Act control healthcare policies and the regulatory environment for biomaterials in Germany. The Medical Device Regulation (MDR) and the In Vitro Diagnostic Regulation (IVDR) of the European Union must be complied with by biomaterials used in medical devices and prostheses in Germany (IVDR). The MDR and IVDR outline the legal specifications for in vitro diagnostics and medical devices in terms of their efficacy, quality, and safety. The regulations demand a comprehensive assessment of the biocompatibility, mechanical attributes, and degradation traits of biomaterials used in medical devices.

1. Executive Summary
1.1 Device Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Regulatory Landscape for Medical Device
1.6 Health Insurance Coverage in Country
1.7 Type of Medical Device
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Biomaterials in Healthcare Market Segmentation

By Type (Revenue, USD Billion):

Based on type, the market is segmented into Metallic Biomaterials, Polymeric Biomaterials, Ceramic Biomaterials, and Natural Biomaterials. The Metallic Biomaterials segment accounted for the largest share of the Germany market in 2019. The growing geriatric population Germanyly is expected to drive growth for this segment.

Metallic Biomaterials
- Stainless Steel
- Titanium & Titanium Alloys
- Cobalt-Chrome Alloys
- Gold
- Silver
- Magnesium
Polymeric Biomaterials
- Polymethylmethacrylate
- Polyethylene
- Polyester
- Silicone Rubber
- Nylon
- Polyetheretherketone
- Other Polymeric Biomaterials
Ceramics
- Calcium Phosphate
- Zirconia
- Aluminum Oxide
- Calcium Sulfate
- Carbon
- Glass
Natural Biomaterials
- Hyaluronic Acid
- Collagen
- Gelatin
- Fibrin
- Cellulose
- Chitin
- Alginates
- Silk

By Application (Revenue, USD Billion):

The cardiovascular, orthopaedic, dental, plastic surgery, wound healing, tissue engineering, ophthalmology, neurological/CNS, and other applications segments are made up of the biomaterials market. The market category for wound healing is anticipated to have the highest CAGR in 2019. The market will increase as a result of factors including expanding healthcare infrastructure, a large population pool, a rising diabetic population, and rising healthcare spending. Surgical Guides

Cardiovascular
- Catheters
- Stents
- Implantable Cardiac Defibrillators
- Pacemakers
- Sensors
- Heart Valves
- Vascular Grafts
- Guidewires
- Others
Orthopedic
- Joint Replacement
  - Knee Replacement
  - Hip Replacement
  - Shoulder Replacement
  - Others
- Viscosupplementation
- Bioresorbable Tissue Fixation
- Spine?
  - Spinal Fusion Surgeries
  - Minimally Invasive Fusion Surgeries
  - Motion Preservation & Dynamic Stabilization Surgeries
    - Pedicle-Based Rod Systems
    - Interspinous Spacers
    - Artificial Discs
- Fracture Fixation Devices
  - Bone Plates
  - Screws
  - Pins
  - Rods
  - Wires
- Synthetics Bone Grafts
Ophthalmology
- Contact Lenses
  - Intraocular Lenses
  - Functional Replacement of Ocular Tissues
  - Synthetic Corneas
  - Others
Dental
- Dental Implants
- Dental Bone Grafts & Substitutes
- Dental Membranes
- Tissue Regeneration
Plastic Surgery
- Soft-Tissue Fillers
- Craniofacial Surgery
Wound Healing
- Wound Closure Devices
  - Sutures
  - Staples
- Surgical Hemostats
- Internal Tissue Sealants
- Adhesion Barriers
- Hernia Meshes
Tissue Engineering
- Scaffolds for Regenerative Medicine
- Nanomaterials for Biosensing
- Tailoring of Inorganic Nanoparticles
  ?
Neurological/Central Nervous System Applications
- Shunting Systems
- Cortical Neural Prosthetics
- Hydrogel Scaffolds for CNS Repair
- Neural Stem Cell Encapsulation
  ?
Other Applications
- Drug Delivery Systems
- Gastrointestinal Applications
- Bariatric Surgery
- Urinary Applications

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.